medigraphic.com
ISSN 2078-7170 (Electronic)

2021, Number 2

<< Back Next >>

CorSalud 2021; 13 (2)

Design of an educational program on food-drug interactions in the elderly with cardiovascular disease

Jiménez FL, Chala TJM, Armada EZ, García AM, Padrón OR, García AM, del Río PBR

Language: Spanish
References: 24
Page: 179-188
PDF size: 716.03 Kb.


ABSTRACT

Introduction: Food-drug interactions may be caused by alterations in pharmacokinetic mechanisms. Most problems occur during drug absorption. The result may be a variation in bioavailability and could have clinical repercussions. Healthcare professionals should receive ongoing education to optimize treatment.
Objective: To identify possible drug-food interactions in patients with cardiovascular diseases and develop an educational program to increase the level of information.
Method: We conducted a descriptive study on the characteristics of drug and food administration in the elderly. We analyzed the medical records of 35 patients with cardiovascular disease from a Nursing Home and conducted an individual interview with patients and healthcare workers. We also analyzed the drugs and food prescribed, as well as their respective administration schedules. Finally, an educational program was designed.
Results: High blood pressure was the most frequent cardiovascular disease (77.2%), which is why antihypertensive drugs are the most frequently prescribed. In most cases, they are administered together with food (80.0%). Based on the deficiencies found, we began the design of an educational program. We created a poster and agreed to hold educational talks for the patients on general aspects of the subject. Moreover, we offered a postgraduate course for the healthcare staff on pharmacokinetics, foods that modify it, and administration schedules.
Conclusions: We were able to ascertain the co-administration of drugs and food. Both patients and healthcare personnel received an educational program based on this aspect.


REFERENCES

  1. San Miguel MT, Vargas E, Martínez A. Interacciones entre medicamentos y alimentos: aspectosactuales. An R Acad Nac Farm. 2004;70(1):147-79.

  2. Araujo DA. Fármaco-nutrimento: interacción insuficientemente considerada. Rev Esp Méd Quir.2014;19(2):244-50.

  3. By the 2019 American Geriatrics Society BeersCriteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria®for Potentially Inappropriate Medication Use inOlder Adults. J Am Geriatr Soc. 2019;67(4):674-694. [DOI]

  4. Lozano C, Villegas FF. Conocimiento detección yprevención de las interacciones fármaco nutrimento en farmacia hospitalaria y farmacovigilancia. En: Araujo D, eds. Generalidades de Nutrición y Fármacos. México: COA Editorial; 2013.p. 40-9.

  5. Cala L, Casas S, Dunán LK. Efecto cascada en elanciano como consecuencia de la polifarmacia.MEDISAN [Internet]. 2017 [citado 12 Feb 2020];21(3):296-303. Disponible en:http://www.medisan.sld.cu/index.php/san/article/view/1030/pdf

  6. Katzung BG. Special Aspects of Geriatric Pharmacology. In: Katzung BG, eds. Basic & ClinicalPharmacology. 14 ed. San Francisco: McGrawHill; 2018. p. 1058-67.

  7. Kenneth E, Thummel D, Isoherrane N. Diseño yoptimización de regímenes posológicos: datosfarmacocinéticos. En: Brunton LL, eds. Goodman& Gilman. Las Bases Farmacológicas de la Terapéutica. 13 ed. México: McGraw-Hill; 2018. p.1891-935.

  8. De Cos MA. Interacciones de fármacos y sus implicaciones clínicas. En: Flórez J, eds. Farmacología Humana. 6 ed. España: Elsevier; 2014. p.178-92.

  9. Araujo-López DA. Interacciones fármaco-nutrimento, una realidad en la práctica clínica hospitalaria. Rev Esp Méd Quir. 2015;20(2):125-34.

  10. Díaz G. Interacción fármaco-nutriente. Medwave[Internet]. 2006 [citado 15 Feb 2020];6(11):e3524.Disponible en:https://doi.org/10.5867/medwave.2006.11.3524

  11. Ritter JM, Flower R, Henderson G, Loke YK, MacEwan D, Rang HP. Rang and Dale’s Pharmacology. 9th ed. Londres: Elsevier; 2020. p. 117-132.

  12. Ramírez Pérez AR, Ramírez Pérez JF, Borrell Zayas JC. Polifarmacia e interacciones medicamentosas potenciales en el adulto mayor, una polémica en la prescripción. Rev Cuba Farm [Internet]. 2019 [citado 15 Feb 2020];52(2):e335. Disponible en:http://www.revfarmacia.sld.cu/index.php/far/article/view/335/217

  13. Castro-Rodríguez JA, Orozco-Hernández JP, Marín-Medina DS. Polifarmacia y prescripción demedicamentos potencialmente no apropiados enancianos. Rev Méd Risaralda. 2015;21(2):52-7.

  14. Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: A review of glycemic control in older adults with type 2 diabetes. JAMA. 2016;315(10):1034-45. [DOI]

  15. Castañeda R, Chacaliaza LR, Espinoza G, Mauricio S. Interacción alimento-medicamento en laindicación terapéutica del paciente quirúrgicodel Hospital EsSalud. 2013. Lima-Perú [Internet].Universidad Peruana de Ciencias Aplicadas. 2013[citado 21 Feb 2020]. Disponible en:http://hdl.handle.net/10757/322127

  16. Hernández Ugalde F, Álvarez Escobar MC, Martínez Leyva G, Junco Sánchez VL, Valdés Gasmury I, Hidalgo Ruiz M. Polifarmacia en el anciano. Retos y soluciones. Rev Med Electrón [Internet]. 2018 [citado 21 Feb 2020];40(6). Disponible en:http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2640/pdf_542

  17. Ettehad D, Emdin CA, Kiran A, Anderson SG,Callender T, Emberson J, et al. Blood pressurelowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis. Lancet. 2016;387(10022):957-67. [DOI]

  18. Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, et al. Management of acute heartfailure in elderly patients. Arch Cardiovasc Dis.2016;109(6-7):422-30. [DOI]

  19. Roush GC, Sica DA. Diuretics for Hypertension:A review and update. Am J Hypertens. 2016;29(10):1130-7. [DOI]

  20. Kearon C, Akl EA, Ornelas J, Blaivas A, JimenezD, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and ExpertPanel Report. Chest. 2016;149(2):315-52. [DOI]

  21. Pérez Caballero MD, León Álvarez JL, DueñasHerrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubanade diagnóstico, evaluación y tratamiento de lahipertensión arterial. Rev Cuban Med [Internet].2017 [citado 3 Mar 2020];56(4):242-321. Disponible en:http://scielo.sld.cu/pdf/med/v56n4/med01417.pdf

  22. Jiménez Fernández L, Siverio Mota D, ChalaTandrón JM, Brito Ferrer Y, Armada Esmores Z.Factores relacionados con la no adherencia altratamiento farmacológico en hipertensos delPoliclínico XX Aniversario. Diseño de un programa educativo. CorSalud [Internet]. 2017 [citado15 Mar 2020];9(1):10-8. Disponible en:http://www.revcorsalud.sld.cu/index.php/cors/article/view/211/458

  23. Naranjo Rojas A, Arango Arango AC, SánchezÉlago HL, Jaramillo NC, Mora YA, Cruz Mosque ra FE. Efectos de un programa educativo paracuidadores de pacientes con afecciones respiratorias en el domicilio. Rev Cuban Med Gen Integr [Internet]. 2019 [citado 15 Mar 2020];35(4).Disponible en:http://revmgi.sld.cu/index.php/mgi/article/view/922/306

  24. Menor Rodríguez MJ, Aguilar Cordero MJ, MurVillar N, Santana Mur C. Efectividad de las intervenciones educativas para la atención de la salud. Revisión sistemática. Medisur [Internet].2017 [citado 16 Mar 2020];15(1):71-84. Disponibleen:http://www.medisur.sld.cu/index.php/medisur/article/view/3424/2263




2020     |     www.medigraphic.com